- New Hope Liuhe reported a net loss of 1.22 billion yuan for the first half of 2024.
- The company’s revenue for the same period was 49.58 billion yuan.
- Market sentiment has varied with analysts providing 8 buy recommendations.
- Additionally, there is 1 hold recommendation for New Hope Liuhe.
- There is also 1 sell recommendation suggesting some analysts have concerns.
A look at New Hope Liuhe Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 3 | |
Dividend | 1 | |
Growth | 2 | |
Resilience | 2 | |
Momentum | 4 | |
OVERALL SMART SCORE | 2.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
According to SmartKarma Smart Scores, New Hope Liuhe‘s long-term outlook appears positive overall. The company scores well in terms of momentum, indicating a strong upward trend in its performance. This suggests that New Hope Liuhe is currently experiencing favorable market conditions and may continue to see growth in the future. Despite lower scores in areas such as dividend and growth, the company’s resilience score is average, reflecting its ability to withstand market challenges. Additionally, with a decent value score, New Hope Liuhe‘s stock may be considered fairly priced, offering potential for investors.
New Hope Liuhe Co Ltd, known for developing, producing, and marketing animal feeds, also engages in various other business activities such as commercial trading, manufacturing packing materials and chemicals, producing fish oil, and providing consultancy services. With its solid momentum score and diversified business operations, New Hope Liuhe appears to be in a position for sustained growth and stability in the long term, despite lower scores in certain areas. Investors may find New Hope Liuhe an interesting prospect due to its overall positive outlook and diverse business portfolio.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars